Globeflex Capital’s Enzo Biochem, Inc. ENZ Stock Holding History

Globeflex Capital’s Portfolio ENZ Stock Details ENZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-7,880	Closed	-$43K	–	454
2018 Q1	$43K	Sell	7,880 -45	-0.6%	-$317	0.01%	409
2017 Q4	$65K	Hold	7,925	–	–	0.02%	368
2017 Q3	$83K	Hold	7,925	–	–	0.02%	343
2017 Q2	$87K	Sell	7,925 -14,495	-65%	-$135K	0.02%	363
2017 Q1	$188K	Sell	22,420 -201,511	-90%	-$1.42M	0.04%	373
2016 Q4	$1.55M	Sell	223,931 -1,903	-0.8%	-$12.1K	0.39%	69
2016 Q3	$1.15M	Buy	+225,834	New	+$1.35M	0.29%	125
2015 Q2	–	Sell	-179	Closed	-$1K	–	593
2015 Q1	$1K	Buy	+179	New	+$586	﹤0.01%	477

Other funds holding ENZ

EGA

Evermore Global Advisors Summit, New Jersey $26.3M AUM 7.42% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Globeflex Capital's ENZ Position: Q2 2018 in Review

Globeflex Capital sold out of Enzo Biochem, Inc. (ENZ) in Q2 2018, closing a stake of 7,880 shares — an estimated $43K sold.

Globeflex Capital first reported a position in ENZ in Q1 2015 and held it in 8 quarters. The position peaked at $1.55M in Q4 2016. 97 funds tracked by Wall St. Rank hold ENZ as of Q2 2018.

Globeflex Capital reported no remaining Enzo Biochem, Inc. position as of Q2 2018 after selling out during the quarter.
Globeflex Capital sold 7,880 Enzo Biochem, Inc. shares in Q2 2018, an estimated $43K.
Globeflex Capital first reported a position in Enzo Biochem, Inc. in Q1 2015 and held it in 8 quarters.
Globeflex Capital's Enzo Biochem, Inc. position peaked at $1.55M in Q4 2016.
97 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q2 2018.

Based on Globeflex Capital's 13F filing for Q2 2018, filed 10 Aug 2018.